Free Trial

Fonar (FONR) Competitors

Fonar logo
$16.00 +0.08 (+0.50%)
Closing price 04:00 PM Eastern
Extended Trading
$16.13 +0.13 (+0.81%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONR vs. TMCI, OM, CLPT, RXST, NPCE, SNWV, NNOX, CATX, DRTS, and NYXH

Should you be buying Fonar stock or one of its competitors? The main competitors of Fonar include Treace Medical Concepts (TMCI), Outset Medical (OM), ClearPoint Neuro (CLPT), RxSight (RXST), NeuroPace (NPCE), Sanuwave Health (SNWV), Nano-X Imaging (NNOX), Perspective Therapeutics (CATX), Alpha Tau Medical (DRTS), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry.

Fonar vs. Its Competitors

Treace Medical Concepts (NASDAQ:TMCI) and Fonar (NASDAQ:FONR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

Fonar has lower revenue, but higher earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treace Medical Concepts$209.36M1.70-$55.74M-$0.85-6.65
Fonar$102.88M0.96$10.57M$1.2512.80

84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 50.6% of Fonar shares are held by institutional investors. 27.7% of Treace Medical Concepts shares are held by company insiders. Comparatively, 1.6% of Fonar shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Fonar has a net margin of 8.19% compared to Treace Medical Concepts' net margin of -25.14%. Fonar's return on equity of 5.31% beat Treace Medical Concepts' return on equity.

Company Net Margins Return on Equity Return on Assets
Treace Medical Concepts-25.14% -48.69% -24.59%
Fonar 8.19%5.31%3.97%

In the previous week, Treace Medical Concepts and Treace Medical Concepts both had 1 articles in the media. Treace Medical Concepts' average media sentiment score of 1.77 beat Fonar's score of 0.62 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Treace Medical Concepts
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Fonar
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Treace Medical Concepts has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, Fonar has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.

Treace Medical Concepts presently has a consensus target price of $10.52, suggesting a potential upside of 86.14%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, equities analysts clearly believe Treace Medical Concepts is more favorable than Fonar.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treace Medical Concepts
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Fonar
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Treace Medical Concepts beats Fonar on 8 of the 15 factors compared between the two stocks.

Get Fonar News Delivered to You Automatically

Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FONR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FONR vs. The Competition

MetricFonarMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$98.76M$10.25B$5.54B$9.41B
Dividend YieldN/A2.06%3.75%4.03%
P/E Ratio12.8011.7121.0120.09
Price / Sales0.9630.03433.8199.01
Price / Cash5.1722.3936.1658.27
Price / Book0.653.578.125.65
Net Income$10.57M$235.43M$3.25B$257.91M
7 Day Performance0.95%-1.67%0.97%2.09%
1 Month Performance13.80%2.91%7.36%11.13%
1 Year Performance-10.46%-16.44%31.31%18.40%

Fonar Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FONR
Fonar
1.2898 of 5 stars
$16.00
+0.5%
N/A-10.0%$98.76M$102.88M12.80480News Coverage
High Trading Volume
TMCI
Treace Medical Concepts
2.8658 of 5 stars
$5.99
-0.2%
$10.52
+75.6%
-31.4%$376.71M$210.82M-7.05250
OM
Outset Medical
1.463 of 5 stars
$18.81
-3.0%
$29.50
+56.8%
-73.5%$333.31M$113.69M-0.65520News Coverage
CLPT
ClearPoint Neuro
1.7055 of 5 stars
$11.85
+3.9%
$25.00
+111.0%
+57.0%$331.68M$31.39M-15.59110
RXST
RxSight
2.2718 of 5 stars
$7.74
-3.3%
$18.44
+138.3%
-84.4%$314.53M$148.31M-11.55220Analyst Downgrade
High Trading Volume
NPCE
NeuroPace
3.5917 of 5 stars
$9.55
+0.3%
$17.00
+78.0%
+20.9%$313.23M$84.31M-11.37170Positive News
SNWV
Sanuwave Health
N/A$36.16
+4.0%
N/AN/A$309.39M$36.19M-7.9440
NNOX
Nano-X Imaging
2.2068 of 5 stars
$5.15
+1.8%
$9.50
+84.5%
-40.5%$297.57M$11.28M-5.72190Positive News
CATX
Perspective Therapeutics
2.3466 of 5 stars
$4.00
+0.5%
$12.56
+213.9%
-65.5%$296.91MN/A0.0070
DRTS
Alpha Tau Medical
3.1713 of 5 stars
$3.23
+5.6%
$8.00
+147.7%
+45.0%$273.97MN/A-7.0280News Coverage
Gap Up
High Trading Volume
NYXH
Nyxoah
2.5681 of 5 stars
$7.84
+3.7%
$14.50
+84.9%
-10.0%$267.03M$4.36M-3.68110Positive News

Related Companies and Tools


This page (NASDAQ:FONR) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners